Neurotrophic and Neuroprotective Actions of (−)- and (+)-Phenserine, Candidate Drugs for Alzheimer’s Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurotrophic and Neuroprotective Actions of (−)- and (+)-Phenserine, Candidate Drugs for Alzheimer’s Disease
Authors
Keywords
Alzheimers disease, Stem cells, Cell proliferation, Drug metabolism, Mouse models, Oxidative stress, Neurons, Neurospheres
Journal
PLoS One
Volume 8, Issue 1, Pages e54887
Publisher
Public Library of Science (PLoS)
Online
2013-01-31
DOI
10.1371/journal.pone.0054887
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenserine Efficacy in Alzheimer's Disease
- (2017) Bengt Winblad et al. JOURNAL OF ALZHEIMERS DISEASE
- 2012 Alzheimer’s disease facts and figures
- (2012) Alzheimers & Dementia
- Neurogenesis and progenitor cells in the adult human brain: A comparison between hippocampal and subventricular progenitor proliferation
- (2012) Maurice A. Curtis et al. Developmental Neurobiology
- Economic Evaluation of Treatment Options in Patients with Alzheimerʼs Disease
- (2012) Laura Pouryamout et al. DRUGS
- New and emerging treatments for Alzheimer's disease
- (2012) Anne Corbett et al. EXPERT OPINION ON EMERGING DRUGS
- Monosynaptic inputs to new neurons in the dentate gyrus
- (2012) Carmen Vivar et al. Nature Communications
- Soluble Aβ oligomer production and toxicity
- (2011) Megan E. Larson et al. JOURNAL OF NEUROCHEMISTRY
- Rivastigmine Lowers Aβ and Increases sAPPα Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons
- (2011) Jason A. Bailey et al. PLoS One
- The cholinergic system, nerve growth factor and the cytoskeleton
- (2010) Grazyna Niewiadomska et al. BEHAVIOURAL BRAIN RESEARCH
- Probing the Biology of Alzheimer's Disease in Mice
- (2010) Karen H. Ashe et al. NEURON
- β-Amyloid 1-42 Oligomers Impair Function of Human Embryonic Stem Cell-Derived Forebrain Cholinergic Neurons
- (2010) Linn Wicklund et al. PLoS One
- Lost in Translation: Neuropsychiatric Drug Development
- (2010) R. E. Becker et al. Science Translational Medicine
- Delayed treatment with a p53 inhibitor enhances recovery in stroke brain
- (2009) Yu Luo et al. ANNALS OF NEUROLOGY
- Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
- (2009) Mark P. Mattson Annals of the New York Academy of Sciences
- Cholinergic Involvement in Alzheimer’s Disease. A Link with NGF Maturation and Degradation
- (2009) A. Claudio Cuello et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
- (2009) Anatoly Nikolaev et al. NATURE
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
- (2009) Alan H Nagahara et al. NATURE MEDICINE
- Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease
- (2009) Sarah M. Rothman et al. NEUROMOLECULAR MEDICINE
- The Cost of Dementia in Europe
- (2009) Linus Jönsson et al. PHARMACOECONOMICS
- Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
- (2008) Ahmadul Kadir et al. ANNALS OF NEUROLOGY
- Oxidative Stress Signaling in Alzheimers Disease
- (2008) B. Su et al. Current Alzheimer Research
- Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair
- (2008) Thomas. J. Nelson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments
- (2007) Ellen Skarpen et al. FASEB JOURNAL
- BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory?
- (2007) Yuan Lu et al. NEUROBIOLOGY OF LEARNING AND MEMORY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation